Selective modulation of muscarinic receptor subtypes: therapeutic potential

By Eglen R.M.   Hegde S.S.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 67-80

Informa Healthcare

Access to resources Recommend Favorite

Muscarinic M1 receptor agonists and M2 receptor antagonists as therapeutic targets in Alzheimer’s disease

By Sheardown Malcolm J  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 863-870

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Opportunities from the Pharmacological Manipulation of the Fas System

By Maggi C.A.L.B.E.R.T.O.  

Pharmacological Research, Vol. 38, Iss. 1, 1998-07 ,pp. : 1-34

Academic Press

Access to resources Recommend Favorite

Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47

By Soto-Pantoja David R   Stein Erica V   Rogers Natasha M   Sharifi-Sanjani Maryam   Isenberg Jeffrey S   Roberts David D  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 89-103

Informa Healthcare

Access to resources Recommend Favorite

Muscarinic Receptor Antagonists

By Watson N.   Eglen R.M.  

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 2, 1999-04 ,pp. : 115-118

Academic Press

Access to resources Recommend Favorite